WEREWOLF THERAPEUTICS (HOWL) Q3 2025 TL;DR
CRITICAL LIQUIDITY WARNING: Management reports substantial doubt regarding the ability to continue as a going concern for the next twelve months, necessitating immediate pursuit of substantial additional financing, collaborations, or licensing to fund operations. The company reported zero revenue for the nine months ended September 30, 2025, as the final performance obligations for the Jazz collaboration were completed in June 2024.
FINANCIAL PERFORMANCE (9M Ended 9/30/2025): The consolidated Net Loss widened to \((52.44M)\) versus $(50.12
...